Physicians who hold an Indiana Controlled Substance Registration (CSR) need look no further than ISMA’s website for resources to help satisfy the new opioid continuing medical education (CME) requirement: More than a dozen webinars on the topic of opioid prescribing and abuse are available for CME credit to count toward the new requirement, at absolutely no charge.

Archived sessions of past webinars presented by respected Indiana experts may be viewed at physicians’ convenience. Topics include the history of the opioid epidemic, treatment models, difficult conversations with patients, new laws for Indiana controlled substance prescribers, and others customized for different medical specialties.

CME credit earned by completing each module of ISMA’s opioid webinar series is free, thanks to a grant from the Richard M. Fairbanks Foundation. Read descriptions of the archived webinars and to register >> 

The new law, which stems from Senate Enrolled Act 225 (P.L.55-2018), requires any Indiana-licensed health care practitioner applying for or renewing a CSR to have completed two hours of CME on opioid prescribing and abuse during the previous two years. The requirement takes effect July 1, 2019, and sunsets on July 1, 2025. The Indiana Medical Licensing Board’s website has more information about the requirement.

ISMA’s free opioid webinars count toward satisfying the two-hour CME requirement, given the content of the webinars and because ISMA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME. For questions regarding the new CME requirement, contact ISMA General Counsel Chelsea Kurth, JD, at (317) 261-2060.